EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Infliximab for Crohns Disease One units experience



Infliximab for Crohns Disease One units experience



Gut 50(Supplement 2): A76, April




(PDF emailed within 1 workday: $29.90)

Accession: 035130674

Download citation: RISBibTeXText



Related references

Infliximab therapy for Crohns disease The Crohns and colitis center of New Jersey experience. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1334, April, 2000

Infliximab in Crohns disease An office-based gastroenterologists community experience. American Journal of Gastroenterology 95(9): 2495, September, 2000

Treatment of Crohns disease with infliximab An initial community practice experience. Gastroenterology 118(4 Suppl 2 Part 1): AGA A567, April, 2000

Preliminary clinical experience with Infliximab in the treatment of refractory and fistulizing Crohns disease. Gastroenterology 118(4 Suppl 2 Part 1): AGA A565, April, 2000

Collaborative experience of open-label infliximab in refractory pediatric Crohns disease. JPGN 31(Supplement 2): S227, 2000

Infliximab treatment for Crohns disease treated with elemental diet The Tokyo experience. American Journal of Gastroenterology 98(9 Supplement): S252-S253, September, 2003

The safety profile of infliximab for crohns disease in clinical practice the mayo clinic experience in 500 patients. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 64, 2003

Effects of antibodies to infliximab on safety and efficacy of infliximab treatment in patients with Crohns disease. Gastroenterology 122(4 Suppl 1): A 613-A 614, April, 2002

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing crohns disease receiving maintenance treatment with infliximab. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1598, 2003

Relationship of antibodies to infliximab to duration of response and infusion reactions for crohns disease patients receiving episodic infliximab retreatment in accent i. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1586, 2003

The use of infliximab in pediatric Crohns disease. Gastroenterology 120(5 Supplement 1): A 210, April, 2001

Infliximab therapy for fistulizing Crohns disease. American Journal of Gastroenterology 95(9): 2635, September, 2000

Infliximab is not a bridge to immunomodulators in crohns disease. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No T1360, 2003

Treatment of cutaneous Crohns disease with infliximab. American Journal of Gastroenterology 98(9 Supplement): S250-S251, September, 2003

Crohns disease, infliximab treatment and IgA nephropathy. American Journal of Gastroenterology 98(9 Supplement): S199, September, 2003